AAAAAA
Results:
1-20
|
Results: 20
Authors:
BENAZIZALOYA R
LEVANON D
KARN H
KIDRON D
GOLDENBERG D
LOTEM J
POLAKCHAKLON S
GRONER Y
Citation: R. Benazizaloya et al., EXPRESSION OF AML1-D, A SHORT HUMAN AML1 ISOFORM, IN EMBRYONIC STEM-CELLS SUPPRESSES IN-VIVO TUMOR-GROWTH AND DIFFERENTIATION, Cell death and differentiation, 5(9), 1998, pp. 765-773
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, DIFFERENT MECHANISMS FOR SUPPRESSION OF APOPTOSIS BY CYTOKINES AND CALCIUM MOBILIZING COMPOUNDS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(8), 1998, pp. 4601-4606
Authors:
GRONER Y
SEGAL M
BARPELED O
KORKATIAN E
PELEDKAMAR M
LOTEM J
WEINER L
WIRGUIN I
Citation: Y. Groner et al., ENGINEERED ANIMAL-MODELS FOR OXIDATIVE STRESS-MEDIATED NEURONAL CELL-DEATH, Neuroscience letters, 1997, pp. 22-22
Authors:
GRONER Y
BARPELED O
PELED M
LOTEM J
Citation: Y. Groner et al., TG-CUZNSOD MICE DISPLAY THYMIC ABNORMALITIES AND ENHANCED APOPTOSIS OF THYMOCYTES AND CULTURED NEURONS, Cytogenetics and cell genetics, 79(1-2), 1997, pp. 48-48
Authors:
PELEDKAMAR M
LOTEM J
WIRGUIN I
WEINER L
HERMALIN A
GRONER Y
Citation: M. Peledkamar et al., OXIDATIVE STRESS MEDIATES IMPAIRMENT OF MUSCLE FUNCTION IN TRANSGENICMICE WITH ELEVATED LEVEL OF WILD-TYPE CU ZN SUPEROXIDE-DISMUTASE/, Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3883-3887
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, DIFFERENTIAL SUPPRESSION BY PROTEASE INHIBITORS AND CYTOKINES OF APOPTOSIS INDUCED BY WILD-TYPE P53 AND CYTOTOXIC AGENTS (VOL 93, PG 12507,1996), Proceedings of the National Academy of Sciences of the United Statesof America, 94(4), 1997, pp. 1603-1603
CYTOKINE SUPPRESSION OF PROTEASE ACTIVATION IN WILD-TYPE P53-DEPENDENT AND P53-INDEPENDENT APOPTOSIS
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, CYTOKINE SUPPRESSION OF PROTEASE ACTIVATION IN WILD-TYPE P53-DEPENDENT AND P53-INDEPENDENT APOPTOSIS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(17), 1997, pp. 9349-9353
Authors:
LEVANON D
BERNSTEIN Y
NEGREANU V
GHOZI MC
BARAM I
ALOYA R
GOLDENBERG D
LOTEM J
GRONER Y
Citation: D. Levanon et al., A LARGE VARIETY OF ALTERNATIVELY SPLICED AND DIFFERENTIALLY EXPRESSEDMESSENGER-RNAS ARE ENCODED BY THE HUMAN ACUTE MYELOID-LEUKEMIA GENE AML1, DNA and cell biology, 15(3), 1996, pp. 175-185
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, CONTROL OF APOPTOSIS IN HEMATOPOIESIS AND LEUKEMIA BY CYTOKINES, TUMOR-SUPPRESSOR AND ONCOGENES, Leukemia, 10(6), 1996, pp. 925-931
Authors:
KAPLINSKY C
LOTEM J
SACHS L
Citation: C. Kaplinsky et al., PROTECTION OF HUMAN MYELOID LEUKEMIC-CELLS AGAINST DOXORUBICIN-INDUCED APOPTOSIS BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3, Leukemia, 10(3), 1996, pp. 460-465
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, DIFFERENTIAL SUPPRESSION BY PROTEASE INHIBITORS AND CYTOKINES OF APOPTOSIS INDUCED BY WILD-TYPE P53 AND CYTOTOXIC AGENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(22), 1996, pp. 12507-12512
Authors:
LOTEM J
PELEDKAMAR M
GRONER Y
SACHS L
Citation: J. Lotem et al., CELLULAR OXIDATIVE STRESS AND THE CONTROL OF APOPTOSIS BY WILD-TYPE P53, CYTOTOXIC COMPOUNDS, AND CYTOKINES, Proceedings of the National Academy of Sciences of the United Statesof America, 93(17), 1996, pp. 9166-9171
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, REGULATION OF BCL-2, BCL-X(L) AND BAX IN THE CONTROL OF APOPTOSIS BY HEMATOPOIETIC CYTOKINES AND DEXAMETHASONE, Cell growth & differentiation, 6(6), 1995, pp. 647-653
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, INTERFERON-GAMMA INHIBITS APOPTOSIS INDUCED BY WILD-TYPE P53, CYTOTOXIC ANTICANCER AGENTS AND VIABILITY FACTOR DEPRIVATION IN MYELOID CELLS, Leukemia, 9(4), 1995, pp. 685-692
Authors:
PELEDKAMAR M
LOTEM J
OKON E
SACHS L
GRONER Y
Citation: M. Peledkamar et al., THYMIC ABNORMALITIES AND ENHANCED APOPTOSIS OF THYMOCYTES AND BONE-MARROW CELLS IN TRANSGENIC MICE OVEREXPRESSING CU ZN-SUPEROXIDE DISMUTASE - IMPLICATIONS FOR DOWN-SYNDROME/, EMBO journal, 14(20), 1995, pp. 4985-4993
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, A MUTANT P53 ANTAGONIZES THE DEREGULATED C-MYC-MEDIATED ENHANCEMENT OF APOPTOSIS AND DECREASE IN LEUKEMOGENICITY, Proceedings of the National Academy of Sciences of the United Statesof America, 92(21), 1995, pp. 9672-9676
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, CONTROL OF SENSITIVITY TO INDUCTION OF APOPTOSIS IN MYELOID LEUKEMIC-CELLS BY DIFFERENTIATION AND BCL-2 DEPENDENT AND INDEPENDENT PATHWAYS, Cell growth & differentiation, 5(3), 1994, pp. 321-327
Authors:
SACHS L
LOTEM J
Citation: L. Sachs et J. Lotem, THE NETWORK OF HEMATOPOIETIC CYTOKINES, Proceedings of the Society for Experimental Biology and Medicine, 206(3), 1994, pp. 170-175
Authors:
LOTEM J
SACHS L
Citation: J. Lotem et L. Sachs, HEMATOPOIETIC-CELLS FROM MICE DEFICIENT IN WILD-TYPE P53 ARE MORE RESISTANT TO INDUCTION OF APOPTOSIS BY SOME AGENTS, Blood, 82(4), 1993, pp. 1092-1096
Authors:
SACHS L
LOTEM J
Citation: L. Sachs et J. Lotem, CONTROL OF PROGRAMMED CELL-DEATH IN NORMAL AND LEUKEMIC-CELLS - NEW IMPLICATIONS FOR THERAPY, Blood, 82(1), 1993, pp. 15-21
Risultati:
1-20
|